134 related articles for article (PubMed ID: 26138491)
1. Does Anticholinergic Activity Affect Neuropathology? Implication of Neuroinflammation in Alzheimer's Disease.
Yoshiyama Y; Kojima A; Itoh K; Isose S; Koide M; Hori K; Arai K
Neurodegener Dis; 2015; 15(3):140-8. PubMed ID: 26138491
[TBL] [Abstract][Full Text] [Related]
2. Anticholinergics boost the pathological process of neurodegeneration with increased inflammation in a tauopathy mouse model.
Yoshiyama Y; Kojima A; Itoh K; Uchiyama T; Arai K
Neurobiol Dis; 2012 Jan; 45(1):329-36. PubMed ID: 21889983
[TBL] [Abstract][Full Text] [Related]
3. Beyond the Hypothesis of Serum Anticholinergic Activity in Alzheimer's Disease: Acetylcholine Neuronal Activity Modulates Brain-Derived Neurotrophic Factor Production and Inflammation in the Brain.
Hachisu M; Konishi K; Hosoi M; Tani M; Tomioka H; Inamoto A; Minami S; Izuno T; Umezawa K; Horiuchi K; Hori K
Neurodegener Dis; 2015; 15(3):182-7. PubMed ID: 26138497
[TBL] [Abstract][Full Text] [Related]
4. Donepezil inhibits the amyloid-beta oligomer-induced microglial activation in vitro and in vivo.
Kim HG; Moon M; Choi JG; Park G; Kim AJ; Hur J; Lee KT; Oh MS
Neurotoxicology; 2014 Jan; 40():23-32. PubMed ID: 24189446
[TBL] [Abstract][Full Text] [Related]
5. The cholinergic system in aging and neuronal degeneration.
Schliebs R; Arendt T
Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
[TBL] [Abstract][Full Text] [Related]
6. SorLA deficiency dissects amyloid pathology from tau and cholinergic neurodegeneration in a mouse model of Alzheimer's disease.
Capsoni S; Carlo AS; Vignone D; Amato G; Criscuolo C; Willnow TE; Cattaneo A
J Alzheimers Dis; 2013; 33(2):357-71. PubMed ID: 22986780
[TBL] [Abstract][Full Text] [Related]
7. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
8. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation, and pathology.
van Groen T; Miettinen P; Kadish I
J Alzheimers Dis; 2011; 24(2):301-13. PubMed ID: 21239852
[TBL] [Abstract][Full Text] [Related]
9. [Neurodegeneration and inflammation: analysis of a FTDP-17 model mouse].
Yoshiyama Y
Rinsho Shinkeigaku; 2008 Nov; 48(11):910-2. PubMed ID: 19198115
[TBL] [Abstract][Full Text] [Related]
10. [Proposal of endogenous anticholinergic hypothesis in Alzheimer disease].
Hori K; Konishi K; Akita R; Tani M; Tomioka H; Kitajima Y; Yokoyama S; Azuma K; Ikuse D; Akashi N; Yuda H; Hachisu M
Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Jun; 33(3):117-26. PubMed ID: 25069245
[TBL] [Abstract][Full Text] [Related]
11. Mouse models of Alzheimer's disease: the long and filamentous road.
Phinney AL; Horne P; Yang J; Janus C; Bergeron C; Westaway D
Neurol Res; 2003 Sep; 25(6):590-600. PubMed ID: 14503012
[TBL] [Abstract][Full Text] [Related]
12. Systemic infection modifies the neuroinflammatory response in late stage Alzheimer's disease.
Rakic S; Hung YMA; Smith M; So D; Tayler HM; Varney W; Wild J; Harris S; Holmes C; Love S; Stewart W; Nicoll JAR; Boche D
Acta Neuropathol Commun; 2018 Sep; 6(1):88. PubMed ID: 30193587
[TBL] [Abstract][Full Text] [Related]
13. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
Saul A; Sprenger F; Bayer TA; Wirths O
Neurobiol Aging; 2013 Nov; 34(11):2564-73. PubMed ID: 23747045
[TBL] [Abstract][Full Text] [Related]
14. Activation of cell cycle proteins in transgenic mice in response to neuronal loss but not amyloid-beta and tau pathology.
Lopes JP; Blurton-Jones M; Yamasaki TR; Agostinho P; LaFerla FM
J Alzheimers Dis; 2009; 16(3):541-9. PubMed ID: 19276549
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition.
Stumm C; Hiebel C; Hanstein R; Purrio M; Nagel H; Conrad A; Lutz B; Behl C; Clement AB
Neurobiol Aging; 2013 Nov; 34(11):2574-84. PubMed ID: 23838176
[TBL] [Abstract][Full Text] [Related]
16. Microglia as a potential bridge between the amyloid beta-peptide and tau.
Kitazawa M; Yamasaki TR; LaFerla FM
Ann N Y Acad Sci; 2004 Dec; 1035():85-103. PubMed ID: 15681802
[TBL] [Abstract][Full Text] [Related]
17. How Anticholinergic Drugs Might Promote Alzheimer's Disease: More Amyloid-β and Less Phosphatidylcholine.
Wurtman RJ
J Alzheimers Dis; 2015; 46(4):983-7. PubMed ID: 26402628
[TBL] [Abstract][Full Text] [Related]
18. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
19. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model.
Cheng XR; Zhou WX; Zhang YX
Ageing Res Rev; 2014 Jan; 13():13-37. PubMed ID: 24269312
[TBL] [Abstract][Full Text] [Related]
20. Activated human microglia stimulate neuroblastoma cells to upregulate production of beta amyloid protein and tau: implications for Alzheimer's disease pathogenesis.
Lee M; McGeer E; McGeer PL
Neurobiol Aging; 2015 Jan; 36(1):42-52. PubMed ID: 25169677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
